MicroRNAs targeting the SARS-CoV-2 entry receptor ACE2 in cardiomyocytes
Dongchao Lu(Medizinische Hochschule Hannover), Thomas Thum(Medizinische Hochschule Hannover)
Cited by 106
Related Papers
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society
|European Journal of Heart Failure|2020|767
Role of Cardiovascular Imaging in Cancer Patients Receiving Cardiotoxic Therapies: A Position Statement on Behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC)
|European Journal of Heart Failure|2020|364
The continuous heart failure spectrum: moving beyond an ejection fraction classification
|European Heart Journal|2019|258
Circulating Endothelial Progenitor Cells in Patients With Eisenmenger Syndrome and Idiopathic Pulmonary Arterial Hypertension
|Circulation|2008|225
Regulated microRNAs in the CSF of patients with multiple sclerosis
|Neurology|2012|160